Clinical Study
The Effect of Amifostine on Submandibular Gland Histology after Radiation
Table 1
Patient demographics.
| Parameter | Amifostine | Partial-amifostine | No-amifostine | -value |
| Number | 5 | 9 | 10 | | Mean age | 60 | 58 | 58 | 0.871 | 95% confidence interval | 45.5–74.1 | 52.3–63.1 | 53.6–62.0 | | Range | 45–70 | 50–71 | 48–68 | | Mean days since end of treatment | 88 | 89 | 81 | 0.851 | 95% confidence interval | 39.1–137.1 | 68.5–110.4 | 58.2–105.0 | | Range | 46–134 | 55–151 | 46–139 | | Mean amifostine dose | 17 | 5 | 0 | 0.00011 | 95% Confidence Interval | 13–21.8 | 3.7–7.2 | 0 | | Range | 12–21 | 1–9 | 0 | | Mean Pack Years | 28 | 20 | 41 | 0.31 | 95% confidence interval | −6.2–62.2 | −3.5–43.9 | 21.8–60.3 | | Range | 0−70 | 0–87.5 | 0–100 | | Gender | | | | 12 | Male | 5 | 6 | 8 | | Female | 0 | 3 | 2 | | Stage | | | | 0.402 | IVA | 4 | 7 | 9 | | IVB | 1 | 2 | 1 | | Site | | | | 0.0062 | Oropharynx | 5 | 9 | 5 | | Hypopharynx | 0 | 0 | 4 | | Larynx | 0 | 0 | 1 | |
|
|
1ANOVA.
2Fisher’s Exact Test.
|